Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Taraneh Mousavi, Shekoufeh Nikfar & Mohammad Abdollahi. (2022) The pharmacotherapeutic management of duodenal and gastric ulcers. Expert Opinion on Pharmacotherapy 23:1, pages 63-89.
Read now
Read now
Aitor Lanas-Gimeno, Gonzalo Hijos & Ángel Lanas. (2019) Proton pump inhibitors, adverse events and increased risk of mortality. Expert Opinion on Drug Safety 18:11, pages 1043-1053.
Read now
Read now
Articles from other publishers (17)
In-Ae Song, Tak-kyu Oh & Sang-Hwan Do. (2023) Trends in Perioperative Magnesium Sulfate Use in Patients Who Underwent Major Cancer Surgery: A Retrospective Population-Based Cohort Study in South Korea. Cancer Control 30, pages 107327482311809.
Crossref
Crossref
Sherry Seah, Yen Kheng Tan, Kevin Teh, Wann Jia Loh, Pei Ting Tan, Leng Chuan Goh, Roy Debajyoti Malakar, Tar Choon Aw, Chin Shern Lau, Trishpal Dhalliwal, Swee Leng Kui, Jia Wen Kam, Joan Khoo, Tunn Lin Tay, Eberta Tan, Vanessa Au, Shui Boon Soh, Meifen Zhang, Thomas F. King, Linsey Gani & Troy H. Puar. (2023) Proton-pump inhibitor use amongst patients with severe hypomagnesemia. Frontiers in Pharmacology 14.
Crossref
Crossref
Ryuichi Kambayashi, Ai Goto, Hiroko Izumi-Nakaseko, Yoshinori Takei & Atsushi Sugiyama. (2023) <i>In vivo</i> analysis of acute eletropharmacological effects of proton pump inhibitors using halothane-anesthetized dogs: a translational study of cardiovascular adverse events. The Journal of Toxicological Sciences 48:7, pages 375-385.
Crossref
Crossref
Lacey B. Robinson & Melanie A. Ruffner. (2022) Proton Pump Inhibitors in Allergy: Benefits and Risks. The Journal of Allergy and Clinical Immunology: In Practice 10:12, pages 3117-3123.
Crossref
Crossref
Lisanne M. M. Gommers, Joost G. J. Hoenderop & Jeroen H. F. de Baaij. (2022) Mechanisms of proton pump inhibitor‐induced hypomagnesemia. Acta Physiologica 235:4.
Crossref
Crossref
Onur Tasci & Ezgi Kiran Tasci. (2022) Does the use of proton pump inhibitors in children affect ventricular repolarisation parameters?. Cardiology in the Young, pages 1-5.
Crossref
Crossref
Elvira Ingrid Levy, Sebastien Kindt, Melina Simon & Yvan Vandenplas. 2022. Gastroesophageal Reflux in Children. Gastroesophageal Reflux in Children
307
318
.
Marco Rossi, Federico Marzi, Mariarita Natale, Aristotele Porceddu, Marco Tuccori, Pietro Enea Lazzerini, Franco Laghi-Pasini & Pier Leopoldo Capecchi. (2021) Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine. Drugs - Real World Outcomes 8:3, pages 325-335.
Crossref
Crossref
Hongzhou Guo, Zhishuai Ye & Rongchong Huang. (2021) Clinical Outcomes of Concomitant Use of Proton Pump Inhibitors and Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Crossref
George Liamis, Ewout J. Hoorn, Matilda Florentin & Haralampos Milionis. (2021) An overview of diagnosis and management of drug‐induced hypomagnesemia. Pharmacology Research & Perspectives 9:4.
Crossref
Crossref
Pietro Enea Lazzerini, Alessandra Cartocci, Yongxia Sarah QuSimona Saponara, Simone Furini, Fabio Fusi, Frank Fabris, Alessandra Gamberucci, Nabil El-Sherif, Gabriele Cevenini, Francesco Pettini, Franco Laghi-Pasini, Maurizio Acampa, Iacopo BertolozziPier Leopoldo Capecchi, Deana LazaroMohamed Boutjdir. (2021) Proton Pump Inhibitors Directly Block hERG-Potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US Veterans. Circulation: Arrhythmia and Electrophysiology 14:7.
Crossref
Crossref
Gabriele Piuri, Monica Zocchi, Matteo Della Porta, Valentina Ficara, Michele Manoni, Gian Vincenzo Zuccotti, Luciano Pinotti, Jeanette A. Maier & Roberta Cazzola. (2021) Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes. Nutrients 13:2, pages 320.
Crossref
Crossref
Biswadeep Das, Saravana Kumar Ramasubbu, Akash Agnihotri, Barun Kumar & Vikram Singh Rawat. (2021) Leading 20 drug–drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients. Therapeutic Advances in Cardiovascular Disease 15, pages 175394472110588.
Crossref
Crossref
N. Noirclerc, C. Delfanne & A. Dompnier. (2020) Fibrillation atriale et allongement du QT sur hypomagnésémie secondaire à un traitement par inhibiteur de la pompe à protons. Annales de Cardiologie et d'Angéiologie 69:4, pages 201-203.
Crossref
Crossref
Antonis A. Manolis, Theodora A. Manolis, Helen Melita, Niki Katsiki & Antonis S. Manolis. (2020) Proton pump inhibitors and cardiovascular adverse effects: Real or surreal worries?. European Journal of Internal Medicine 72, pages 15-26.
Crossref
Crossref
Biswadeep Das, SaravanaKumar Ramasubbu, Barun Kumar & VikramSingh Rawat. (2020) Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients. Journal of Family Medicine and Primary Care 9:12, pages 6023.
Crossref
Crossref
Antonio Ponzetto & Natale Figura. (2020) Serum magnesium and the prevalence of peripheral artery disease. Atherosclerosis 292, pages 230.
Crossref
Crossref